Waitlist and transplant outcomes for patients bridged to heart transplantation with Impella 5.0 and 5.5 devices.

Morgan A Hill Jennie H KwonKhaled ShorbajiArman Kilic

Published in: Journal of cardiac surgery (2022)

Impella devices can be used as a BTT with excellent survival and minimal post-transplant morbidity. Outcomes were comparable for Impella 5.0 and 5.5 devices.

Keyphrases

end stage renal disease
extracorporeal membrane oxygenation
ejection fraction
newly diagnosed
chronic kidney disease
left ventricular assist device
prognostic factors
peritoneal dialysis
type diabetes
metabolic syndrome
skeletal muscle